Menu
GeneBe

rs769743354

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP2BP4

The NM_001127644.2(GABRA1):c.94C>A(p.Gln32Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000687 in 1,600,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Q32Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000069 ( 0 hom. )

Consequence

GABRA1
NM_001127644.2 missense

Scores

2
2
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 6.80
Variant links:
Genes affected
GABRA1 (HGNC:4075): (gamma-aminobutyric acid type A receptor subunit alpha1) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4. Multiple transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PP2
Missense variant where missense usually causes diseases, GABRA1
BP4
Computational evidence support a benign effect (MetaRNN=0.2953133).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GABRA1NM_001127644.2 linkuse as main transcriptc.94C>A p.Gln32Lys missense_variant 3/10 ENST00000393943.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GABRA1ENST00000393943.10 linkuse as main transcriptc.94C>A p.Gln32Lys missense_variant 3/101 NM_001127644.2 P1

Frequencies

GnomAD3 genomes
AF:
0.00000660
AC:
1
AN:
151476
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000798
AC:
2
AN:
250478
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135406
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000690
AC:
10
AN:
1449270
Hom.:
0
Cov.:
28
AF XY:
0.00000554
AC XY:
4
AN XY:
721918
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000253
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000817
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000660
AC:
1
AN:
151476
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
73964
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000148
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 07, 2017The p.Q32K variant (also known as c.94C>A), located in coding exon 2 of the GABRA1 gene, results from a C to A substitution at nucleotide position 94. The glutamine at codon 32 is replaced by lysine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy;C1970160:Epilepsy, childhood absence 4;C4013473:Epilepsy, idiopathic generalized, susceptibility to, 13 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 29, 2023This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 32 of the GABRA1 protein (p.Gln32Lys). This variant is present in population databases (rs769743354, gnomAD 0.002%). This missense change has been observed in individual(s) with clinical features of GABRA1-related conditions (PMID: 35937053). ClinVar contains an entry for this variant (Variation ID: 536749). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GABRA1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.040
Cadd
Benign
22
Dann
Benign
0.94
DEOGEN2
Benign
0.23
T;T;.;T;T;T;T;T;.;.;T;.;.;T
Eigen
Benign
-0.14
Eigen_PC
Benign
0.063
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.30
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Benign
0.69
N;N;.;N;N;N;.;N;.;.;N;.;.;N
MutationTaster
Benign
1.0
D;D;D;D;D;D
PrimateAI
Uncertain
0.60
T
Polyphen
0.026
B;B;.;B;B;B;.;B;.;.;B;.;.;B
Vest4
0.54, 0.61, 0.55, 0.54
MutPred
0.47
Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);.;Gain of ubiquitination at Q32 (P = 0.009);.;Gain of ubiquitination at Q32 (P = 0.009);Gain of ubiquitination at Q32 (P = 0.009);
MVP
0.99
MPC
1.4
ClinPred
0.29
T
GERP RS
5.5
Varity_R
0.13
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs769743354; hg19: chr5-161281183; API